Studies

Serology and serum DNA detection in shingles

Marinko Dobec, Walter Bossart, Franz Kaeppeli, Juerg Mueller-Schoop
Swiss Medical Weekly SMW (2008) 138, 47-51

Aim of this study was to investigate the sensitivity of various laboratory approaches in the diagnosis of herpes zoster from patient serum.

Rofecoxib improves quality of life in patients with hip or knee osteoarthritis

Robert Theiler, Heike A. Bischoff, Meinrad Good, Daniel Uebelhart
Swiss Medical Weekly SMW (2002) 132, 566-573.

Download of publication PDF, 129.99 KB

The primary aim of this study was to assess the effects of rofecoxib on quality of life in elderly patients with painful osteoarthritis (OA) of the hip or knee, who were not responsive to or had adverse events from previous NSAID-therapy.

Schweizer Erfahrungen mit Rosiglitazon bei Typ-2-Diabetes (Phase III B Studie)

Eric Bandle, Urs Kientsch, Meinrad Good
Ars Medici (2001) 25/26, 1219-1222

Download of publication PDF, 55.95 KB

In dieser bei 28 Diabetologen in der Schweiz durchgeführten Phase-IIIB-Studie wurden 184 Typ-2-Diabetes-Patienten mit dem oralen Antidiabetikum Rosiglitazon während 26 Wochen behandelt, entweder als Monotherapie oder in Kombination mit den bisherigen oralen Antidiabetika.

An Open Multi-Centre Swiss Study on Dose-Dependent Efficacy, Safety and Tolerability of Oral Sumatriptan in The Treatment of Migraine Under Practice Conditions

Gerhard Jenzer, Barbara Henggeler, Meinrad Good, Beat Althaus
Schweiz Arch Neurol Psych (2000) 151 (2), 1- 5.
(No PDF available)

Objectives of this open study were to determine the efficacy, safety and tolerability of the 50 mg and 100 mg oral doses of sumatriptan in migraine patients on an out-patient basis. All patients had to treat the first two attacks with 50 mg. The second treatment with the 100 mg dose of further two attacks was performed solely with those patients who were not content with the treatment of the 50 mg dose.